NASA's InSight Survived the Trip to Mars ー Now Comes the Wait for Results
*By Conor White*
The Curiosity rover is no longer alone on Mars.
NASA's InSight lander successfully touched down on the Red Planet Monday afternoon, but spectators will have months to wait before any results arrive.
"It's a 26-month mission," said Sarah Lewin, an associate editor at Space.com said. The first results from InSight's experiments are expected sometime in the spring.
InSight marks NASA's first mission to Mars since Curiosity began its journey in 2011. The launch was originally scheduled for 2016 before officials discovered a leak in the rocket's vacuum chamber. As a result, InSight missed its launch window. The delay and necessary repairs added almost $154 million to the mission's price tag, bringing it to a total cost of $814 million.
And even those years of planning didn't guarantee a success.
"Mars missions have like a 40 percent success rate across the world," Lewin said. "NASA is a little bit higher, so there was a definite chance it wouldn't work."
Now that it has safely landed, the probe will be responsible for drilling into Mars ー largely to determine the planet's composition. The robot will also monitor the planet for "Marsquakes."
"We've put a lot of things on Mars that are either orbiters, which are looking down on it, or rovers like Curiosity exploring the surface, but we really don't know what's going on inside," Lewin said.
Cheddar's J.D. Durkin caught up with the head of NASA Bill Nelson, a former senator, who feels one thing that seems less rancorous on Capitol Hill these days is the work of the space agency.
Catching you up on what you need to know on April 22, 2022, with updates on a new Ukraine aid package, a new missile test by Russia, DOJ announcement of $150 Million in COVID-related fraud, the Florida senate supports Gov. DeSantis in stripping Disney of its special tax district, and more.
Scientists say a U.K. patient with a severely weakened immune system had COVID-19 for almost a year and a half. The case underscores the importance of protecting vulnerable people from the coronavirus.
Cheddar's Lawrence Banton speaks with entrepreneurs leading the way on textile and clothing recycling in an effort to help stem waste in fashion amid the climate crisis.
The FDA just approved a first-of-its-kind treatment for individuals with blood cancer that has proven results of 5-year survival rates. Christi Shaw, CEO of Kite, a Gilead company, joins Cheddar Innovates to discuss how this treatment works and compares to others currently on the market.
Dr. Neta Lavon, CTO and VP of R&D at Aleph Farms, joins Cheddar Innovates to discuss how the team sent cow cells to space to further research the production of meat in space, and why developing cultivated meat is so critical to the future of space travel.
Catching you up on what you need to know on April 21, 2022, with President Biden set to announce more security assistance funding to Ukraine, polls showing a majority of Americans in favor of transit mask mandates, rapper A$AP Rocky's arrest, and more.
Epidemiologist Dr. Eric Feigl-Ding joined Closing Bell to explain why ending the travel mask mandates could put the U.S. in a bad position in the coming months as new COVID-19 variants threaten to cause another spike in cases.
Laurence Tribe, a professor of constitutional law at Harvard University, joined Cheddar News to talk about the legal underpinnings of the ruling to lift the federal travel mask mandate. "Judge Mizelle decided that she would issue a nationwide injunction, which she and other conservatives have criticized in the past," he said. "That didn't stop her from doing it this time. She did it by just wiping away the CDC's rule, and she did it, have to say, in an opinion that was, well, I'll be honest, really stupid."
